Applicability of fibroblast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients

BACKGROUND: Elderly patients with chronic kidney disease (CKD) are usually at a high risk of fractures due to both osteoporosis and CKD-mineral bone disease (MBD). A new marker is needed to prevent fractures and control CKD-MBD from the early to advanced stages of CKD. In the early stage of CKD, fib...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Eiichiro, Yoshida, Masayuki, Sasaki, Sei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506497/
https://www.ncbi.nlm.nih.gov/pubmed/23013306
http://dx.doi.org/10.1186/1471-2369-13-122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506497/
https://www.ncbi.nlm.nih.gov/pubmed/23013306
http://dx.doi.org/10.1186/1471-2369-13-122

Ejemplares similares